Tannapfel A - Search Results

1

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma.

Rohloff J, Zinke J, Schoppmeyer K, Tannapfel A, Witzigmann H, Mössner J, Wittekind C, Caca K. Rohloff J, et al. Among authors: tannapfel a. Br J Cancer. 2002 Apr 22;86(8):1270-5. doi: 10.1038/sj.bjc.6600232. Br J Cancer. 2002. PMID: 11953884 Free PMC article.

2

Multiple simultaneous gastric carcinomas.

Wittekind C, Klimpfinger M, Hermanek P, Tannapfel A. Wittekind C, et al. Among authors: tannapfel a. Br J Cancer. 1997;76(12):1604-9. doi: 10.1038/bjc.1997.604. Br J Cancer. 1997. PMID: 9413949 Free PMC article.

3

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver.

Tannapfel A, Engeland K, Weinans L, Katalinic A, Hauss J, Mössner J, Wittekind C. Tannapfel A, et al. Br J Cancer. 1999 Jun;80(7):1069-74. doi: 10.1038/sj.bjc.6690465. Br J Cancer. 1999. PMID: 10362118 Free PMC article.

4

Predictive value of heparanase expression in the palliative therapy of pancreatic cancer.

Schoppmeyer K, Kronberg J, Tannapfel A, Mossner J, Wittekind C, Caca K. Schoppmeyer K, et al. Among authors: tannapfel a. Pancreatology. 2005;5(6):570-5. doi: 10.1159/000087499. Epub 2005 Aug 16. Pancreatology. 2005. PMID: 16110255

5

Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.

Caca K, Feisthammel J, Klee K, Tannapfel A, Witzigmann H, Wittekind C, Mössner J, Berr F. Caca K, et al. Among authors: tannapfel a. Int J Cancer. 2002 Feb 1;97(4):481-8. doi: 10.1002/ijc.1639. Int J Cancer. 2002. PMID: 11802210 Free article.

6

Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.

Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A. Weber A, et al. Among authors: tannapfel a. Int J Cancer. 2002 May 1;99(1):22-8. doi: 10.1002/ijc.10296. Int J Cancer. 2002. PMID: 11948487 Free article.

7

Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.

Wiedmann M, Caca K, Berr F, Schiefke I, Tannapfel A, Wittekind C, Mössner J, Hauss J, Witzigmann H. Wiedmann M, et al. Among authors: tannapfel a. Cancer. 2003 Jun 1;97(11):2783-90. doi: 10.1002/cncr.11401. Cancer. 2003. PMID: 12767091 Free article. Clinical Trial.

8

TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor.

Spiesbach K, Tannapfel A, Mössner J, Engeland K. Spiesbach K, et al. Among authors: tannapfel a. Int J Cancer. 2005 Apr 20;114(4):555-62. doi: 10.1002/ijc.20766. Int J Cancer. 2005. PMID: 15578720 Free article.

9

E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases.

Dansranjavin T, Möbius C, Tannapfel A, Bartels M, Wittekind C, Hauss J, Witzigmann H. Dansranjavin T, et al. Among authors: tannapfel a. Oncol Rep. 2006 May;15(5):1125-31. Oncol Rep. 2006. PMID: 16596173

10

Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinib.

Wiedmann M, Feisthammel J, Blüthner T, Tannapfel A, Kamenz T, Kluge A, Mössner J, Caca K. Wiedmann M, et al. Among authors: tannapfel a. Anticancer Drugs. 2006 Aug;17(7):783-95. doi: 10.1097/01.cad.0000217433.48870.37. Anticancer Drugs. 2006. PMID: 16926628

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

633 results

Search Page